XOMA Royalty Corp - Company Profile
Powered by 
All the sales intelligence you need on XOMA Royalty Corp in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how XOMA Royalty Corp fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with XOMA Royalty Corp.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
XOMA Royalty Corp (Xoma) develops and manufactures therapeutic antibodies. The company’s royalty-based approach, existing partnerships, and lead product are the strengths of the company. However, liquidity constraints is an area of concern for the company. Strategic agreement, positive outlook of healthcare market in the US, and strategic acquisition are the opportunities for the company. The competitive landscape, intellectual property risks, and government regulations are the areas of threats for the company.
Strengths
Weaknesses
Opportunities
Threats
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer